Lanzamiento Enero 2027

Ensayo controlado aleatorizado2018Financiado por la industriaAlimentación controlada

Financiado en parte por Abbott Laboratories, Pfizer, PepsiCo, Kellogg's, Coca-Cola Foundation, California Strawberry Commission, Danone, Almond Board of California, Dairy Farmers of Canada, Royal Bank of Canada, Saskatchewan Pulse Growers, Canola Council of Canada, Loblaw Companies Limited, California Walnut Commission, Alpro Foundation, International Nut and Dried Fruit Council, DSM, DSM Company, Dow Agrosciences and Flax Council of Canada

Diets Low in Saturated Fat with Different Unsaturated Fatty Acid Profiles Similarly Increase Serum-Mediated Cholesterol Efflux from THP-1 Macrophages in a Population with or at Risk for Metabolic Syndrome: The Canola Oil Multicenter Intervention Trial

Liu X, Garban J, Jones PJ, Vanden Heuvel J, Lamarche B, Jenkins DJ, Connelly PW, Couture P, Pu S, Fleming JA, West SG, Kris-Etherton PM

The Journal of nutrition · 18 citas

Etiquetas de revisión

Alimentación controladaFinanciado por la industria

Datos neutrales que nuestra revisión registró sobre cómo se hizo este estudio. Describen el método, nunca si nos gusta el resultado.

Cómo se estudió

Diseño
Ensayo controlado aleatorizado (indexado por PubMed)
Estudiado en
Personas
Resultado principal
Marcadores de salud y funcionamiento
Consumo medido con
Comida provista por los investigadores

Quién lo pagó

Financiación
Financiado por la industria
Gobierno
U.S. Department of Agriculture
Empresa
Abbott Laboratories
Empresa
Pfizer
Empresa
PepsiCo
Empresa
Kellogg's
Empresa
Coca-Cola Foundation
Grupo de la industria
California Strawberry Commission
Organización sin fines de lucro
Canadian Diabetes Association
Universidad u hospital
Arizona State University
Empresa
Danone
Grupo de la industria
Almond Board of California
Grupo de la industria
Advanced Foods and Materials Network
Grupo de la industria
Dairy Farmers of Canada
Empresa
Royal Bank of Canada
Grupo de la industria
Saskatchewan Pulse Growers
Organización sin fines de lucro
Canadian Nutrition Society
Grupo de la industria
Canola Council of Canada
Empresa
Loblaw Companies Limited
Organización sin fines de lucro
Danish Cancer Society Research Center
Gobierno
Australian Government
Grupo de la industria
California Walnut Commission
Gobierno
Government of Canada
Universidad u hospital
Hospital for Sick Children
Empresa
Alpro Foundation
Grupo de la industria
International Nut and Dried Fruit Council
Organización sin fines de lucro
Canadian Society of Endocrinology and Metabolism
Empresa
DSM
Gobierno
National Institutes of Health
Gobierno
Canadian Institutes of Health Research
Gobierno
Agriculture and Agri-Food Canada
Gobierno
National Institute of Diabetes and Digestive and Kidney Diseases
Gobierno
National Center for Research Resources
Gobierno
National Center for Advancing Translational Sciences
Universidad u hospital
Institute of Nutrition, Metabolism and Diabetes
Gobierno
NIH
Gobierno
Agriculture and Agri Food Canada
Gobierno
NCRR NIH HHS
Gobierno
NCATS NIH HHS
Empresa
DSM Company
Grupo de la industria
Dow Agrosciences and Flax Council of Canada
Gobierno
NIDDK NIH HHS
Subvenciones
National Institute of Diabetes and Digestive and Kidney Diseases (T-32 DK 007703); National Center for Advancing Translational Sciences (UL1-TR000127); National Center for Advancing Translational Sciences (TR000127); National Center for Research Resources (UL1 RR033184); National Institutes of Health (1ul1rr033184-01); National Center for Research Resources (UL1 TR000127); National Center for Research Resources (RR033184); National Center for Advancing Translational Sciences (RR033184); National Institutes of Health (TR000127); National Institutes of Health (UL1-TR-000127); National Institutes of Health (2T32DK007703)

Según 41 financiadores declarados.

Publicación

Publicado
2018-05-01 · J Nutr · vol. 148 · número 5 · págs. 721–728
Editorial
Elsevier BV
Citado
25 citas · más que el 85% de estudios similares · 2.0× el promedio de su campo
Referencias
38 trabajos
Acceso
Lectura gratuita
Áreas de investigación
Fatty Acid Research and Health · Cholesterol and Lipid Metabolism · Lipoproteins and Cardiovascular Health
Palabras clave
cholesterol efflux capacity, serum cholesterol, THP-1 macrophages, unsaturated fatty acids, monounsaturated fatty acids, polyunsaturated fatty acids, metabolic syndrome, abdominal obesity, abdominal fat, canola oil, corn oil, safflower oil, linseed oil, atherosclerosis
MeSH
humans, cholesterol, lipids, dietary fats, unsaturated, lipoproteins, diet, cross-over studies, middle aged, female, male, thp-1 cells, metabolic syndrome, rapeseed oil

12 autores

  • Xiaoran Liu🇺🇸Pennsylvania State University
  • Josephine Garban🇺🇸Pennsylvania State University
  • Peter J.H. Jones🇨🇦University of Manitoba
  • Jack Vanden Heuvel🇺🇸Pennsylvania State University
  • Benoı̂t Lamarche🇨🇦Université Laval; Institut sur la nutrition et les aliments fonctionnels (INAF)
  • David J.A. Jenkins🇨🇦St. Michael's Hospital; University of Toronto
  • Philip W. Connelly🇨🇦St. Michael's Hospital
  • Patrick Couture🇨🇦Université Laval; Institut sur la nutrition et les aliments fonctionnels (INAF)
  • Shuaihua Pu🇺🇸Pennsylvania State University
  • Jennifer A Fleming🇺🇸Pennsylvania State University
  • Sheila G. West🇺🇸Pennsylvania State University
  • Penny M. Kris‐Etherton🇺🇸 · autor de correspondenciaPennsylvania State University

Resumen

El texto original del estudio, en el idioma en que se publicó.

Background

Cholesterol efflux plays an important role in preventing atherosclerosis progression. Vegetable oils with varying unsaturated fatty acid profiles favorably affect multiple cardiovascular disease risk factors; however, their effects on cholesterol efflux remain unclear.

Objective

The objectives of this study were to examine the effects of diets low in saturated fatty acids (SFAs) with varying unsaturated fatty acid profiles on serum-mediated cholesterol efflux and its association with the plasma lipophilic index and central obesity.

Methods

The present study is a randomized, crossover, controlled-feeding study. Participants [men: n = 50; women: n = 51; mean ± SE age: 49.5 ± 1.2 y; body mass index (in kg/m2): 29.4 ± 0.4] at risk for or with metabolic syndrome (MetS) were randomly assigned to 5 isocaloric diets containing the treatment oils: canola oil, high oleic acid-canola oil, DHA-enriched high oleic acid-canola oil, corn oil and safflower oil blend, and flax oil and safflower oil blend. These treatment oils were incorporated into smoothies that participants consumed 2 times/d. For a 3000-kcal diet, 60 g of treatment oil was required to provide 18% of total energy per day. Each diet period was 4 wk followed by a 2- to 4-wk washout period. We quantified cholesterol efflux capacity with a validated ex vivo high-throughput cholesterol efflux assay. Statistical analyses were performed with the use of the SAS mixed-model procedure.

Results

The 5 diets increased serum-mediated cholesterol efflux capacity from THP-1 macrophages similarly by 39%, 34%, 55%, 49% and 51%, respectively, compared with baseline (P < 0.05 for all). Waist circumference and abdominal adiposity were negatively correlated with serum-mediated cholesterol efflux capacity (r = -0.25, P = 0.01, r = -0.33, P = 0.02, respectively).

Conclusion

Diets low in SFAs with different monounsaturated fatty acid and polyunsaturated fatty acid profiles improved serum-mediated cholesterol efflux capacity in individuals with or at risk for MetS. This mechanism may account, in part, for the cardiovascular disease benefits of diets low in SFAs and high in unsaturated fatty acids. Importantly, central obesity is inversely associated with cholesterol efflux capacity. This trial was registered at www.clinicaltrials.gov as NCT01351012.

Resumen vía Europe PMC. Los derechos de autor siguen siendo de los autores o la editorial.

Confianza de la comunidad

Cargando…

¿Cuánto confías en los hallazgos de este estudio?

0 · nada10 · totalmente

Comentarios

¿Algo está mal aquí?

Señala este estudio si su información, etiquetas o financiación parecen incorrectas. Un editor revisa cada señalamiento.

Información educativa sobre investigación publicada. No es consejo médico ni una recomendación para empezar o dejar nada.